OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced the completion of an expanded license with the Dana-Farber Cancer Institute, Boston, MA, for the COLD-PCR (CO-amplification at Lower Denaturing temperature PCR) technology. Previously, Transgenomic had licensed exclusive rights to COLD-PCR for Sanger Sequencing and mitochondrial DNA analysis. The new license expands the technology covered to […]
Washington, D.C. – Danaher Corporation (NYSE:DHR) announced today that its previously announced tender offer to acquire all of the outstanding shares of Beckman Coulter, Inc. (NYSE: BEC) for $83.50 per share in cash (“the Offer”) has been extended and will now expire at 12:00 midnight, New York City time, at the end of April 27, […]
CARLSBAD, Calif. – Life Technologies Corporation (Nasdaq: LIFE) today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion […]
VANCOUVER, British Columbia – RainDance Technologies, Inc., today announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels. Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder […]
SUNNYVALE, Calif. – Cepheid CPHD today announced that Glenn Steele, Jr., MD, PhD, has been nominated for election to Cepheid’s Board of Directors at the company’s Annual Meeting of Shareholders to be held on April 26, 2011. Dr. Steele has been President and Chief Executive Officer of Geisinger Health System, a physician-led health care system […]
CARLSBAD, Calif. – Life Technologies Corporation (Nasdaq: LIFE) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM — a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States. The StemPro […]
Germantown, MD., and Hilden, Germany – QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced today the proposal of two international leaders in life sciences and healthcare – Dr. Vera Kallmeyer, M.D., Ph.D., and Elizabeth E. Tallett – for election to its Supervisory Board. The Supervisory Board will propose these two independent candidates based on their […]
HOPKINTON, Mass. – Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako(R) i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients […]
CINCINNATI – Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for a new pediatric claim for its illumigene C. difficile (Clostridium difficile) molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in […]
CARLSBAD, Calif. – GenMark Diagnostics Inc. (NASDAQ:GNMK) announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc. The suit sought Declaratory Relief that GenMark does […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
